WO1997013858A3 - Baboon mage-3 homologs, dna encoding the homologs, and a process for their use - Google Patents

Baboon mage-3 homologs, dna encoding the homologs, and a process for their use Download PDF

Info

Publication number
WO1997013858A3
WO1997013858A3 PCT/US1996/016319 US9616319W WO9713858A3 WO 1997013858 A3 WO1997013858 A3 WO 1997013858A3 US 9616319 W US9616319 W US 9616319W WO 9713858 A3 WO9713858 A3 WO 9713858A3
Authority
WO
WIPO (PCT)
Prior art keywords
homologs
mage
baboon
dna encoding
tumors
Prior art date
Application number
PCT/US1996/016319
Other languages
French (fr)
Other versions
WO1997013858A2 (en
Inventor
David B Ring
Robert O Ralston
Original Assignee
Chiron Corp
David B Ring
Robert O Ralston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp, David B Ring, Robert O Ralston filed Critical Chiron Corp
Priority to AU74401/96A priority Critical patent/AU7440196A/en
Publication of WO1997013858A2 publication Critical patent/WO1997013858A2/en
Publication of WO1997013858A3 publication Critical patent/WO1997013858A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Abstract

MAGE-3 tumor antigens are useful for overcoming tolerance to tumors.
PCT/US1996/016319 1995-10-12 1996-10-10 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use WO1997013858A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU74401/96A AU7440196A (en) 1995-10-12 1996-10-10 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US511795P 1995-10-12 1995-10-12
US60/005,117 1995-10-12

Publications (2)

Publication Number Publication Date
WO1997013858A2 WO1997013858A2 (en) 1997-04-17
WO1997013858A3 true WO1997013858A3 (en) 1997-06-05

Family

ID=21714271

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/016319 WO1997013858A2 (en) 1995-10-12 1996-10-10 Baboon mage-3 homologs, dna encoding the homologs, and a process for their use

Country Status (2)

Country Link
AU (1) AU7440196A (en)
WO (1) WO1997013858A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686068A (en) * 1994-03-24 1997-11-11 Ludwig Institute For Cancer Research Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof
US6475727B1 (en) 1997-04-11 2002-11-05 Micromet Gesellschaft Fur Biomedizinische Forschung Mbh Primers and methods for the detection of disseminated tumor cells
US5965535A (en) 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
ES2255248T3 (en) 1998-02-05 2006-06-16 Glaxosmithkline Biologicals S.A. DERIVATIVES OF ANTIGENS ASSOCIATED TO TUMOR OF THE MAGE FAMILY, AND SEQUENCES OF NUCLEIC ACIDS THAT CODIFY THEM, USED FOR THE PREPARATION OF FUSION PROTEINS AND COMPOSITIONS FOR VACCINES.
CA2393339A1 (en) * 1999-12-10 2001-06-14 Epimmune Inc. Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions
US7049413B2 (en) 2001-05-18 2006-05-23 Ludwig Institute For Cancer Research MAGE-A3 peptides presented by HLA class II molecules
WO2010143010A1 (en) * 2009-06-09 2010-12-16 Vaxon Biotech Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023031A1 (en) * 1993-03-26 1994-10-13 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023031A1 (en) * 1993-03-26 1994-10-13 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
B. GAUGLER ET AL.: "HUMAN GENE MAGE-3 CODES FOR AN ANTIGEN RECOGNIZED ON A MELANOMA BY AUTOLOGOUS CYTOLYTIC T LYMPHOCYTES", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 179, no. 3, 1 March 1994 (1994-03-01), pages 921 - 930, XP000614538 *
O. DE BACKER ET AL.: "STRUCTURE, CHROMOSOME LOCATION, AND EXPRESSION PATTERN OF THREE MOUSE GENES HOMOLOGOUS TO THE HUMAN MAGE GENES", GENOMICS, vol. 28, no. 1, 1 July 1995 (1995-07-01), pages 74 - 93, XP000670311 *
PLAEN DE E ET AL: "STRUCTURE, CHROMOSOMAL LOCALIZATION, AND EXPRESSION OF 12 GENES OF THE MAGE FAMILY", IMMUNOGENETICS, vol. 40, no. 5, 1994, pages 360 - 369, XP000614537 *

Also Published As

Publication number Publication date
AU7440196A (en) 1997-04-30
WO1997013858A2 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
AU4903101A (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
AU1218295A (en) Adjuvant for antigens, process for producing the same and its use
AU4293693A (en) Catalyzed cationic lacquer binder, process for producing the same and its use
AU2186095A (en) Biometric, personal authentication system
AU5047800A (en) Breast, gastric and prostate cancer associated antigens and uses therefor
CY2440B1 (en) Process improvement in the synthesis of N-A3-(3-cyanopyrazolo A1,5-aUpyrimidin-7-yl)phenylU-N-ethyl-acetamide.
ZA9711090B (en) Process for the preparation of hydrocarbons.
ZA966441B (en) Hydrocarbon alkylation process.
ZA964711B (en) Novel compounds, the preparation and use thereof.
AU7198291A (en) Human monoclonal antibodies against rabies viruses, the production and the use thereof
EP0660700A4 (en) Method for permanently shaping keratinous materials.
ZA975588B (en) Isolated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof.
WO1997013858A3 (en) Baboon mage-3 homologs, dna encoding the homologs, and a process for their use
ZA9610278B (en) Pyridylcarbamates, processes and intermediates for their preparation, and their use.
ZA974084B (en) Novel α-glucuronidases, production hereof and their uses.
EP0622369A3 (en) 2-Amino-4-quinoline-dihydropyridine, process for preparation and use thereof.
ZA966474B (en) Method for preparing mineral pigments, the thus obtained mineral pigments and installation for implementing such method.
EP0613634A3 (en) Process for producing sticks, especially cosmetic sticks.
AU6609298A (en) Dual tube system, method and tools for the production thereof
AU5997096A (en) Cocoa flavour precursor peptides, dna encoding them, process es for producing the peptides, and their use for generating cocoa flavour
HUP9700747A1 (en) Novel retinoids, pharmaceutical compns. contg. them and process for preparing the said compds.
AU6820198A (en) Cyclodextrin modifications with molecular channels, method for the production and use thereof
EP0614971A3 (en) Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin using the same.
EP0675171A3 (en) Reactive dyes, process for their preparation and the use thereof.
EP0757098A3 (en) Heat resistant maltose phosphorylase, process for preparation thereof, bacteria used for preparation thereof, and methods for using the enzyme

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97515226

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA